A study on PATTAI RASAYANAM and SIRUTHETKODUKKU THYLAM in the treatment of SATTAI KARAPPAN in children

Preclinical and clinical evaluation of PATTAI RASAYANAM (INTERNAL) and PATTAI RASAYANAM (INTERNAL) with SIRUTHETKODUKKU THYLAM (EXTERNAL) in the management of SATTAI KARAPPAN (ATOPIC DERMATITIS) in children - A double arm study - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079272

Enrollment

Registered

2025-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: PATTAI RASAYANAM(INTERNAL): Should be administered orally twice a day after food. Dosage (according to age group and body weight) 3-12 years- 1gms-3gms. Duration 48 days. Control Interv

Eligibility

Inclusion criteria

Inclusion criteria: Both male and female children Erythema Pruritus Oozing Papules Papulovesicles Lichenification Crusted lesions

Exclusion criteria

Exclusion criteria: Children below 3 years Children above 12 years Scabies Psoriasis Other type of dermatitis Dermatophytosis Impetigo Lichen Planus

Design outcomes

Primary

Measure	Time frame
This study shows preclinical and clinical evaluation of PATTAI RASAYANAM(INTERNAL) or PATTAI RASAYANAM(INTERNAL) with SIRUTHETKODUKKU THYLAM (EXTERNAL) in the prognosis of SATTAI KARAPPAN (ATOPIC DERMATITIS) in Children in OPD of Government Siddha Medical College and Hospital PalayamkottaiTimepoint: 2 years	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr S Geetha Devi MD S

Government Siddha Medical College and Hospital, Palayamkottai, Tirunelveli

geethadevis16@yahoo.in7401757475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026